Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anzhelika Vorobyeva

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancers|January 21, 2022
Radionuclides in Diagnostics and Therapy of Malignant Tumors: New DevelopmentVladimir Tolmachev, Anzhelika Vorobyeva
Molecules (Basel, Switzerland)|June 13, 2020
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody MoleculesJavad Garousi, Anzhelika Vorobyeva, Mohamed Altai
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2020
Preparation of Conjugates for Affibody-Based PNA-Mediated PretargetingMohamed Altai, Anzhelika Vorobyeva, Vladimir Tolmachev, et al.
Oncology Letters|December 8, 2022
Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with <sup>99m</sup>Tc and <sup>125</sup>IVladimir Tolmachev, Vitalina Bodenko, Anna Orlova, et al.
EJNMMI Research|February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPinsMohamed Altai, Javad Garousi, Sara S Rinne, et al.
Cancers|January 5, 2021
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse ModelTianqi Xu, Haozhong Ding, Anzhelika Vorobyeva, et al.
Oncology Reports|March 22, 2022
Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cellsTianqi Xu, Yongsheng Liu, Alexey Schulga, et al.
Biomaterials|March 17, 2019
Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargetingKristina Westerlund, Anzhelika Vorobyeva, Bogdan Mitran, et al.
International Journal of Molecular Sciences|June 26, 2019
Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular ImagingAnzhelika Vorobyeva, Alexey Schulga, Sara S Rinne, et al.
Cancers|August 17, 2019
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug ConjugatesHaozhong Ding, Mohamed Altai, Sara S Rinne, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancers|January 21, 2022
Radionuclides in Diagnostics and Therapy of Malignant Tumors: New DevelopmentVladimir Tolmachev, Anzhelika Vorobyeva
Molecules (Basel, Switzerland)|June 13, 2020
Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody MoleculesJavad Garousi, Anzhelika Vorobyeva, Mohamed Altai
Methods in Molecular Biology (Clifton, N.J.)|February 24, 2020
Preparation of Conjugates for Affibody-Based PNA-Mediated PretargetingMohamed Altai, Anzhelika Vorobyeva, Vladimir Tolmachev, et al.
Oncology Letters|December 8, 2022
Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with <sup>99m</sup>Tc and <sup>125</sup>IVladimir Tolmachev, Vitalina Bodenko, Anna Orlova, et al.
EJNMMI Research|February 6, 2020
On the prevention of kidney uptake of radiolabeled DARPinsMohamed Altai, Javad Garousi, Sara S Rinne, et al.
Cancers|January 5, 2021
Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse ModelTianqi Xu, Haozhong Ding, Anzhelika Vorobyeva, et al.
Oncology Reports|March 22, 2022
Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cellsTianqi Xu, Yongsheng Liu, Alexey Schulga, et al.
Biomaterials|March 17, 2019
Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargetingKristina Westerlund, Anzhelika Vorobyeva, Bogdan Mitran, et al.
International Journal of Molecular Sciences|June 26, 2019
Indirect Radioiodination of DARPin G3 Using N-succinimidyl-<i>Para</i>-Iodobenzoate Improves the Contrast of HER2 Molecular ImagingAnzhelika Vorobyeva, Alexey Schulga, Sara S Rinne, et al.
Cancers|August 17, 2019
Incorporation of a Hydrophilic Spacer Reduces Hepatic Uptake of HER2-Targeting Affibody-DM1 Drug ConjugatesHaozhong Ding, Mohamed Altai, Sara S Rinne, et al.
Pageof 8